{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T20:13:51Z","timestamp":1774296831775,"version":"3.50.1"},"reference-count":57,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"crowdfunding project","award":["PID2019-106487RB-I00\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["PID2019-106487RB-I00\/AEI\/10.13039\/501100011033"]}]},{"name":"crowdfunding project","award":["S2018\/BAA-4370"],"award-info":[{"award-number":["S2018\/BAA-4370"]}]},{"DOI":"10.13039\/501100006541","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["PID2019-106487RB-I00\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["PID2019-106487RB-I00\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100006541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006541","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["S2018\/BAA-4370"],"award-info":[{"award-number":["S2018\/BAA-4370"]}],"id":[{"id":"10.13039\/501100006541","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Complutense University of Madrid","award":["PID2019-106487RB-I00\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["PID2019-106487RB-I00\/AEI\/10.13039\/501100011033"]}]},{"name":"Complutense University of Madrid","award":["S2018\/BAA-4370"],"award-info":[{"award-number":["S2018\/BAA-4370"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Zoonotic leishmaniases are a worldwide public health problem for which the development of effective vaccines remains a challenge. A vaccine against leishmaniases must be safe and affordable and should induce cross-protection against the different disease-causing species. In this context, the DNA vaccine pHisAK70 has been demonstrated to induce, in a murine model, a resistant phenotype against L. major, L. infantum, and L. amazonensis. Moreover, a chimeric multiepitope peptide, HisDTC, has been obtained by in silico analysis from the histone proteins encoded in the DNA vaccine and has showed its ability to activate a potent CD4+ and CD8+ T-cell protective immune response in mice against L. infantum infection. In the present study, we evaluated the plasmid DNA vaccine pHisAK70 in comparison with the peptide HisDTC (with and without saponin) against L. major and L. infantum infection. Our preliminary results showed that both formulations were able to induce a potent cellular response leading to a decrease in parasite load against L. infantum. In addition, the DNA candidate was able to induce better lesion control in mice against L. major. These preliminary results indicate that both strategies are potentially effective candidates for leishmaniases control. Furthermore, it is important to carry out such comparative studies to elucidate which vaccine candidates are the most appropriate for further development.<\/jats:p>","DOI":"10.3390\/ijms241512334","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T11:04:38Z","timestamp":1690974278000},"page":"12334","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Tailored Approach to Leishmaniases Vaccination: Comparative Evaluation of the Efficacy and Cross-Protection Capacity of DNA vs. Peptide-Based Vaccines in a Murine Model"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8947-3207","authenticated-orcid":false,"given":"Alicia","family":"Mas","sequence":"first","affiliation":[{"name":"INMIVET Group, Animal Health Department, Veterinary School, Universidad Complutense Madrid, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Hurtado-Morillas","sequence":"additional","affiliation":[{"name":"INMIVET Group, Animal Health Department, Veterinary School, Universidad Complutense Madrid, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3405-7171","authenticated-orcid":false,"given":"Abel","family":"Mart\u00ednez-Rodrigo","sequence":"additional","affiliation":[{"name":"INMIVET Group, Animal Science Department, Veterinary School, Universidad Complutense Madrid, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6352-1426","authenticated-orcid":false,"given":"Jos\u00e9 A.","family":"Orden","sequence":"additional","affiliation":[{"name":"INMIVET Group, Animal Health Department, Veterinary School, Universidad Complutense Madrid, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"de la Fuente","sequence":"additional","affiliation":[{"name":"INMIVET Group, Animal Health Department, Veterinary School, Universidad Complutense Madrid, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7693-653X","authenticated-orcid":false,"given":"Gustavo","family":"Dom\u00ednguez-Bernal","sequence":"additional","affiliation":[{"name":"INMIVET Group, Animal Health Department, Veterinary School, Universidad Complutense Madrid, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7486-4942","authenticated-orcid":false,"given":"Javier","family":"Carri\u00f3n","sequence":"additional","affiliation":[{"name":"INMIVET Group, Animal Health Department, Veterinary School, Universidad Complutense Madrid, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Fabrizio Bruschi, L.G. (2018). The Leishmaniases: Old Neglected Tropical Diseases, Springer International Publishing.","DOI":"10.1007\/978-3-319-72386-0"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Akhoundi, M., Kuhls, K., Cannet, A., Votypka, J., Marty, P., Delaunay, P., and Sereno, D. (2016). A Historical Overview of the Classification, Evolution, and Dispersion of Leishmania Parasites and Sandflies. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0004349"},{"key":"ref_3","unstructured":"World Health Organization (2021, November 29). Status of Endemicity of Cutaneous and Visceral Leishmaniasis. Available online: https:\/\/www.who.int\/health-topics\/leishmaniasis#tab=tab_1."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Rodriguez-Morales, A.J. (2019). Current Topics in Neglected Tropical Diseases, IntechOpen.","DOI":"10.5772\/intechopen.73918"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"174436","DOI":"10.1016\/j.ejphar.2021.174436","article-title":"Advancement in leishmaniasis diagnosis and therapeutics: An update","volume":"910","author":"Kumari","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/infdis\/156.1.73","article-title":"Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis","volume":"156","author":"Jones","year":"1987","journal-title":"J. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1179\/2047773213Y.0000000098","article-title":"Three Leishmania\/L. species\u2014L. infantum, L. major, L. tropica\u2014as causative agents of mucosal leishmaniasis in Iran","volume":"107","author":"Shirian","year":"2013","journal-title":"Pathog. Glob. Health"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/archdischild-2015-309302","article-title":"Visceral leishmaniasis: A forgotten epidemic","volume":"101","author":"Zijlstra","year":"2016","journal-title":"Arch. Dis. Child."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid2512.190164","article-title":"Canine Leishmaniasis Control in the Context of One Health","volume":"25","author":"Miro","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1756-3305-4-86","article-title":"LeishVet guidelines for the practical management of canine leishmaniosis","volume":"4","author":"Miro","year":"2011","journal-title":"Parasit. Vectors"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.cvsm.2022.06.012","article-title":"Leishmaniasis","volume":"52","author":"Baneth","year":"2022","journal-title":"Vet. Clin. N. Am. Small Anim. Pract."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/labmed\/lmac134","article-title":"Review of the Clinical Presentation, Pathology, Diagnosis, and Treatment of Leishmaniasis","volume":"54","author":"Mathison","year":"2022","journal-title":"Lab. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1017\/S003118201600216X","article-title":"Leishmaniasis and various immunotherapeutic approaches","volume":"145","author":"Taslimi","year":"2018","journal-title":"Parasitology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/14760584.2018.1459191","article-title":"Vaccine candidates against leishmania under current research","volume":"17","author":"Iborra","year":"2018","journal-title":"Expert. Rev. Vaccines"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/tmi.13382","article-title":"Commercially approved vaccines for canine leishmaniosis: A review of available data on their safety and efficacy","volume":"25","author":"Velez","year":"2020","journal-title":"Trop. Med. Int. Health"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.plasmid.2018.12.002","article-title":"The antibiotic resistance-free mammalian expression plasmid vector pPAL for development of third generation vaccines","volume":"101","author":"Alcolea","year":"2019","journal-title":"Plasmid"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6695","DOI":"10.1016\/j.vaccine.2020.08.051","article-title":"Immunoprophylaxis pharmacotherapy against canine leishmaniosis: A systematic review and meta-analysis on the efficacy of vaccines approved in European Union","volume":"38","author":"Calzetta","year":"2020","journal-title":"Vaccine"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.vetpar.2019.04.011","article-title":"An investigation of polymorphisms in innate and adaptive immune response genes in canine leishmaniosis","volume":"269","author":"Soutter","year":"2019","journal-title":"Vet. Parasitol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri.2016.72","article-title":"Cutaneous leishmaniasis: Immune responses in protection and pathogenesis","volume":"16","author":"Scott","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1186\/s13071-015-1246-y","article-title":"HisAK70: Progress towards a vaccine against different forms of leishmaniosis","volume":"8","author":"Horcajo","year":"2015","journal-title":"Parasit. Vectors"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Martinez-Rodrigo, A., Mas, A., Alvarez-Campos, D., Orden, J.A., Dominguez-Bernal, G., and Carrion, J. (2020). Epitope Selection for Fighting Visceral Leishmaniosis: Not All Peptides Function the Same Way. Vaccines, 8.","DOI":"10.3390\/vaccines8030352"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1038\/s41598-017-03662-4","article-title":"Canine Leishmaniasis Progression is Associated with Vitamin D Deficiency","volume":"7","author":"Martori","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jcpa.2015.10.174","article-title":"Impairment of Interleukin-17A Expression in Canine Visceral Leishmaniosis is Correlated with Reduced Interferon-\u03b3 and Inducible Nitric Oxide Synthase Expression","volume":"153","author":"Nascimento","year":"2015","journal-title":"J. Comp. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"eaau6085","DOI":"10.1126\/sciimmunol.aau6085","article-title":"Structure and function of the immune system in the spleen","volume":"4","author":"Lewis","year":"2019","journal-title":"Sci. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.4049\/jimmunol.1701597","article-title":"CD8+ T Cells Lack Local Signals To Produce IFN-gamma in the Skin during Leishmania Infection","volume":"200","author":"Novais","year":"2018","journal-title":"J. Immunol."},{"key":"ref_26","first-page":"340","article-title":"Sustained parasite burden in the spleen of Leishmania infantum-infected BALB\/c mice is accompanied by expression of MCP-1 transcripts and lack of protection against challenge","volume":"12","author":"Rousseau","year":"2001","journal-title":"Eur. Cytokine Netw."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12026-007-8012-y","article-title":"L-arginine metabolism and its impact on host immunity against Leishmania infection","volume":"41","author":"Wanasen","year":"2008","journal-title":"Immunol. Res."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Duthie, M.S., Machado, B.A.S., Badaro, R., Kaye, P.M., and Reed, S.G. (2022). Leishmaniasis Vaccines: Applications of RNA Technology and Targeted Clinical Trial Designs. Pathogens, 11.","DOI":"10.3390\/pathogens11111259"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Zutshi, S., Kumar, S., Chauhan, P., Bansode, Y., Nair, A., Roy, S., Sarkar, A., and Saha, B. (2019). Anti-Leishmanial Vaccines: Assumptions, Approaches, and Annulments. Vaccines, 7.","DOI":"10.3390\/vaccines7040156"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.coi.2014.01.009","article-title":"Challenges and responses in human vaccine development","volume":"28","author":"Kaufmann","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40475-021-00232-7","article-title":"A Review of Leishmaniasis: Current Knowledge and Future Directions","volume":"8","author":"Mann","year":"2021","journal-title":"Curr. Trop. Med. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Alvar, J., Velez, I.D., Bern, C., Herrero, M., Desjeux, P., Cano, J., Jannin, J., den Boer, M., and WHO Leishmaniasis Control Team (2012). Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0035671"},{"key":"ref_33","unstructured":"Gradoni, L., and Bruschi, F. (2018). The Leishmaniases: Old Neglected Tropical Diseases, Sprincer International Publishing."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Bruschi, F., and Gradoni, L. (2018). The Leishmaniases: Old Neglected Tropical Diseases, Springer International Publishing.","DOI":"10.1007\/978-3-319-72386-0"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cimid.2019.05.009","article-title":"Strength and medium-term impact of HisAK70 immunization in dogs: Vaccine safety and biomarkers of effectiveness for ex vivo Leishmania infantum infection","volume":"65","author":"Mas","year":"2019","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Martinez-Rodrigo, A., Dias, S.D., Ribeiro, P.A.F., Roatt, B.M., Mas, A., Carrion, J., Coelho, E.A.F., and Dominguez-Bernal, G. (2019). Immunization with the HisAK70 DNA Vaccine Induces Resistance against Leishmania Amazonensis Infection in BALB\/c Mice. Vaccines, 7.","DOI":"10.3390\/vaccines7040183"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5964","DOI":"10.1016\/j.vaccine.2009.07.069","article-title":"The chimerical multi-component Q protein from Leishmania in the absence of adjuvant protects dogs against an experimental Leishmania infantum infection","volume":"27","author":"Iniesta","year":"2009","journal-title":"Vaccine"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat. Rev. Drug. Discov."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.3389\/fimmu.2017.01437","article-title":"The Equivocal Role of Th17 Cells and Neutrophils on Immunopathogenesis of Leishmaniasis","volume":"8","author":"Pessoa","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cellimm.2016.07.010","article-title":"Memory T cells in cutaneous leishmaniasis","volume":"309","author":"Glennie","year":"2016","journal-title":"Cell. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1084\/jem.20142101","article-title":"Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection","volume":"212","author":"Glennie","year":"2015","journal-title":"J. Exp. Med."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Agallou, M., Margaroni, M., Kotsakis, S.D., and Karagouni, E. (2020). A Canine-Directed Chimeric Multi-Epitope Vaccine Induced Protective Immune Responses in BALB\/c Mice Infected with Leishmania infantum. Vaccines, 8.","DOI":"10.3390\/vaccines8030350"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Brito, R.C.F., Ruiz, J.C., Cardoso, J.M.O., Ostolin, T., Reis, L.E.S., Mathias, F.A.S., Aguiar-Soares, R.D.O., Roatt, B.M., Corr\u00eaa-Oliveira, R., and Resende, D.M. (2020). Chimeric Vaccines Designed by Immunoinformatics-Activated Polyfunctional and Memory T Cells That Trigger Protection against Experimental Visceral Leishmaniasis. Vaccines, 8.","DOI":"10.3390\/vaccines8020252"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fimmu.2018.00018","article-title":"Liposomal Elongation Factor-1\u03b1 Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral Leishmaniasis","volume":"9","author":"Sabur","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.imbio.2016.08.009","article-title":"Leishmania infantum antigens modulate memory cell subsets of liver resident T lymphocyte","volume":"222","author":"Rodrigues","year":"2017","journal-title":"Immunobiology"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Margaroni, M., Agallou, M., Tsanaktsidou, E., Kammona, O., Kiparissides, C., and Karagouni, E. (2023). Immunoinformatics Approach to Design a Multi-Epitope Nanovaccine against Leishmania Parasite: Elicitation of Cellular Immune Responses. Vaccines, 11.","DOI":"10.3390\/vaccines11020304"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.pt.2019.04.002","article-title":"CD4+ T Cell-Mediated Immunity against the Phagosomal Pathogen Leishmania: Implications for Vaccination","volume":"35","author":"Hohman","year":"2019","journal-title":"Trends Parasitol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Novais, F.O., Carvalho, A.M., Clark, M.L., Carvalho, L.P., Beiting, D.P., Brodsky, I.E., Carvalho, E.M., and Scott, P. (2017). CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1beta production. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006196"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Carrion, J., Abengozar, M.A., Fernandez-Reyes, M., Sanchez-Martin, C., Rial, E., Dominguez-Bernal, G., and Gonzalez-Barroso, M.M. (2013). UCP2 deficiency helps to restrict the pathogenesis of experimental cutaneous and visceral leishmaniosis in mice. PLoS Negl. Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002077"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4049\/jimmunol.139.1.221","article-title":"Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes","volume":"139","author":"Scott","year":"1987","journal-title":"J. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"19.2.1","DOI":"10.1002\/0471142735.im1902s108","article-title":"Animal models for the analysis of immune responses to leishmaniasis","volume":"108","author":"Sacks","year":"2015","journal-title":"Curr. Protoc. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cimid.2017.07.002","article-title":"Alternative strategy for visceral leishmaniosis control: HisAK70-Salmonella Choleraesuis-pulsed dendritic cells","volume":"54","author":"Mas","year":"2017","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1128\/AAC.39.9.2167","article-title":"Culture microtitration: A sensitive method for quantifying Leishmania infantum in tissues of infected mice","volume":"39","author":"Buffet","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_54","first-page":"191","article-title":"Generation of murine bone-marrow-derived dendritic cells","volume":"64","author":"Maroof","year":"2001","journal-title":"Methods Mol. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1590\/0037-8682-0120-2016","article-title":"Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis","volume":"49","author":"Duarte","year":"2016","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.141.7.2407","article-title":"Release of Reactive Nitrogen Intermediates and Reactive Oxygen Intermediates from Mouse Peritoneal-Macrophages\u2014Comparison of Activating Cytokines and Evidence for Independent Production","volume":"141","author":"Ding","year":"1988","journal-title":"J. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.7150\/ijbs.7.1257","article-title":"The Increase in Mannose Receptor Recycling Favors Arginase Induction and Trypanosoma Cruzi Survival in Macrophages","volume":"7","author":"Garrido","year":"2011","journal-title":"Int. J. Biol. Sci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/15\/12334\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:24:15Z","timestamp":1760127855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/15\/12334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,2]]},"references-count":57,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["ijms241512334"],"URL":"https:\/\/doi.org\/10.3390\/ijms241512334","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,2]]}}}